Multimodality Adjuvant Therapy Associated with Improved Survival in Uterine Carcinosarcoma; Oral Presentation (2020 SGO 25th Annual Winter Meeting)

​

Outcomes of MSI high advanced-stage endometrial cancer treated with chemotherapy and radiation versus chemotherapy alone; Oral Presentation (SGO Annual Meeting 2020)

​

Evaluation of the optimal sequence of chemotherapy and radiation therapy in the treatment of advanced endometrial cancer (SGO Annual Meeting 2020)

​

Beyond Sedlis: A novel, histology-based nomogram for predicting recurrence risk and need for adjuvant radiation in cervical cancer--A NRG/GOG ancillary analysis (ASCO Annual Meeting 2020)

​

Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancer undergoing cytoreductive surgery (ASCO Annual Meeting 2020)
 

PD-L1 expression, DNA mismatch repair genes, and HPV types in cervical squamous cell carcinoma (ASCO Annual Meeting 2019)

​

Clinical comparison between neuroendocrine tumor and endometrioid type carcinoma of the uterine corpus (IGCS 2018)

​

Epidemiology and clinical trends of gynecological neuroendocrine tumors in the US (IGCS 2018)

​

Expression Pattern and Clinical Significance of PD-1 and PD-L1 in Squamous Cell Carcinoma of the Cervix (SGO Annual Meeting 2019)

​

Changing Patterns in Care Settings for Surgical Management of Ovarian and Uterine Malignancies (SGO Annual Meeting 2019)

​

Trends in Sentinel Lymph Node Biopsy in Vulvar Carcinoma (SGO Annual Meeting 2019)

​

Prediction of Neutropenia with First-Line Chemotherapy in Patients with Gynecologic Cancers (SGO Annual Meeting 2019)
 

Molecular profiling of endometrial carcinomas in a Caribbean Black population (ASCO Annual Meeting 2018)

​

Do we understand patients’ supportive care needs? Validation and results of a novel need assessment tool for gynecologic oncology patients (SGO Annual Meeting 2018)

​

GOG 8035: Nuclear BRCA1 loss may identify a poor prognostic subgroup of women with locally advanced cervical cancer treated with cisplatin-based chemoradiation: An NRG Oncology study. Poster presentation (SGO Annual Meeting 2018)

​

A comparison between vulvar melanoma and vulvar squamous cell carcinoma and other mucocutaneous melanomas with a focus on racial disparities (SGO Annual Meeting 2018)

​

Hospice utilization in advanced cervical malignancies: An analysis of the national inpatient sample (SGO Annual Meeting 2018)

​

Perioperative complications in elderly patients undergoing hysterectomy for gynecologic malignancies (SGO Annual Meeting 2018)

​

Molecular profiling of endometrial carcinomas in a Caribbean Black population (SGO Annual Winter Meeting 2018)

​

Microscopic versus gross tumor in Stage IB1 cervical cancer treated with radical hysterectomy: Is there a difference? International Meeting of the European Society of Gynecological Oncology (ESGO 2017)

​

​Association of TOP2a and TP53 with Nuclear Atypia in Endometrial Cancers.  The Academy of Clinical Laboratory Physicians and Scientists 2017 Annual Meeting

​

Evaluation of Foxp3-Positive Tumor-Infiltrating Lymphocytes in Uterine Carcinosarcomas. The Academy of Clinical Laboratory Physicians and Scientists 2017 Annual Meeting

​

Vaginal Cancer Treatment Patterns and its Associated Disparities. Poster presentation (SGO Annual Meeting 2017)

 

Sociodemographic Factors Associated with Advanced Vulvar Cancer Stage (International GYN Cancer Society, Lisbon, October 2016)

​

Practice Patterns and Disparities of Sentinel Lymph Node Biopsy in Vulvar Cancer Patients (International GYN Cancer Society, Lisbon, October 2016)

​

External Validation of a Nomogram Predicting Vulvar Cancer Patient Survival Using a U.S. Population (International GYN Cancer Society, Lisbon, October 2016)

​

External validation of nomograms predicting survival of women with locally

advanced cervical cancer (SGO Annual Meeting 2016)

​

Relationship of Locus of Control and Depression to Treatment Adherence in Gynecologic Oncology Patients (SGO Annual Meeting 2015)

 

A retrospective assessment of the role of radiation in the treatment of uterine carcinosarcoma. (SGO Annual Meeting 2015)

 

Survival impact of cytoreduction to microscopic disease for advanced stage cancer of the uterine corpus (SGO Annual Meeting 2014)

 

Extent of lymph node dissection and overall survival in patients with uterine carcinosarcoma, papillary serous and endometrioid adenocarcinoma (SGO Annual Meeting 2014)

 

Tumor cells surviving the cytotoxic effect of Paclitaxel are sensitized to anti-cancer peptide PNC-27 (SGO Annual Meeting 2014)

 

Glassy Cell Carcinoma of the Cervix: A Systematic Review and Meta-Analysis (SGO Annual Meeting 2013)

 

Routine cystoscopy after robotic gynecologic oncology surgery: Increasing urinary injury detection or simply achieving medical-legal benefit? (SGO Annual Meeting 2013)

 

Beyond the dark side of the moon: Evaluating the quality of web-based information at the end of life (SGO Annual Meeting 2013)

 

Defining Practice Patterns: What is “Standard” Postoperative Care? A Survey of the SGO Membership (SGO Annual Meeting 2013)

 

The diagnostic utility and cost-analysis of endometrial biopsy versus dilation and curettage in detecting papillary serous carcinomas of the uterus (SGO Annual Meeting 2012)

 

Examining the Role of Preoperative Computed Tomography in Serous Uterine Cancers (SGO Annual Meeting 2012)

 

Hemoglobin A1c and the Relationship to Stage and Grade of Endometrial Cancer (ACOG Annual Meeting 2012)

 

Impact of Race and Age on Duration Between Surgery and Chemotherapy in Epithelial Ovarian Cancer (city Research  Day 2012 & WAGO 2012)

 

Nationwide Chemotherapy Drug Shortages and the Impact on Patients with Gynecologic Malignancy at a Single Institution (SGO Winter Conference 2012)

 

But where is the β-hCG coming from? (WAGO Tumor Board 2012)

 

FIGO Staging for Carcinosarcoma: Can the New Staging System Predict Overall Survival? (SGO Annual Meeting 2011)

 

Does the New Sarcoma Staging System Better Predict Overall Survival for Leiomyosarcoma? (SGO Annual Meeting 2011)